On September 7, 2021 Viracta Therapeutics, Inc. (NASDAQ: VIRX), a precision oncology company targeting virus-associated malignancies, reported that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, September 20 – 23, 2021, and the 2021 Cantor Virtual Global Healthcare Conference, September 27 – 30, 2021 (Press release, Viracta Therapeutics, SEP 7, 2021, View Source [SID1234587351]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details on the presentations can be found below.
H.C. Wainwright 23rd Annual Global Investment Conference
Presentation Date:
Corporate presentation will be available on-demand to conference
registrants starting at 7:00 AM ET on September 13, 2021
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Presentation Date:
September 21, 2021
Presentation Time:
4:35 PM ET
Format:
Corporate presentation
Webcast Link:
2021 Cantor Virtual Global Healthcare Conference
Presentation Date:
September 30, 2021
Presentation Time:
8:40 AM ET
Format:
Corporate presentation
A replay of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit presentation will be available on the "Events and Webcasts" section of the Viracta website at View Source